PD-L1 expression was identified on both tumour cells and on the immune stroma of 12% and 42% of gastric adenocarcinoma patients undergoing surgical tumour resection, respectively (Thompson et al. 2017). This evidence concerns the gene CD274 and gastric adenocarcinoma.